Chestnut (Castanea sativa)

Chestnut (Castanea sativa) contains bioactive polyphenols including ellagitannins, gallotannins, and flavonoids that drive its primary health effects through inhibition of pro-inflammatory cytokine signaling and oxidative stress pathways. These compounds, particularly castalagin and vescalagin, suppress NF-κB activation and neutralize reactive oxygen species to produce anti-inflammatory and antimutagenic outcomes documented in preliminary cell-based research.

Origin & History

Castanea sativa (European chestnut) is a deciduous tree native to southern Europe, western Asia, and North Africa, with edible nuts harvested as the primary ingredient. Extracts are typically obtained from nuts and by-products (leaves, bark, burs, shells) via decoction, infusion, or ethanol-water extraction, yielding polyphenol-rich derivatives containing ursene derivatives, flavonoids, and tannins.

Historical & Cultural Context

Castanea sativa has been used in Mediterranean traditional medicine for respiratory and gastrointestinal infections, skin inflammations, and soft tissue infections. Leaf and nut preparations have been documented in southern European folk remedies for treating various skin conditions.

Health Benefits

• Anti-inflammatory effects: In vitro studies show extracts inhibit inflammatory mediators (CXCL-10, MCP-1, IL-8) with IC50 values of 10-50 µg/mL in intestinal cells (preliminary evidence)
• Antimutagenic activity: Bark extracts (3-12 µg/mL) reduced chemically-induced DNA damage in human cells without cytotoxicity (preliminary evidence)
• Antimicrobial support: Leaf extracts quench bacterial quorum sensing in Staphylococcus and Streptococcus without growth inhibition (preliminary evidence)
• Digestive health support: Extracts maintain bioactivity after simulated digestion, suggesting potential gastrointestinal benefits (preliminary evidence)
• Skin health: Traditional use for skin conditions supported by modern patch testing showing no irritation in 20 volunteers (limited evidence)

How It Works

Castanea sativa polyphenols, notably the ellagitannins castalagin and vescalagin, suppress NF-κB nuclear translocation, thereby downregulating transcription of pro-inflammatory chemokines including CXCL-10, MCP-1, and IL-8 in intestinal epithelial cells at IC50 values of 10–50 µg/mL. Bark-derived gallotannins also inhibit topoisomerase II and modulate CYP1A1 enzyme activity, contributing to the antimutagenic effects observed when bark extracts (3–12 µg/mL) reduce chemically-induced DNA strand breaks in human cell models. Additionally, chestnut phenolics scavenge superoxide and hydroxyl radicals by donating hydrogen atoms from their catechol and pyrogallol moieties, reducing lipid peroxidation end-products such as malondialdehyde.

Scientific Research

Current evidence is limited to preclinical in vitro and in vivo animal studies, with no human clinical trials, RCTs, or meta-analyses identified. Key studies include CaCo-2 intestinal cell research demonstrating anti-inflammatory effects at 10-50 µg/mL IC50 values, and TK6 cell studies showing antimutagenic properties at 3-18 µg/mL concentrations.

Clinical Summary

Available evidence for Castanea sativa health effects is largely confined to in vitro and animal studies, with very limited human clinical data published to date. Cell-based experiments demonstrate that chestnut bark extracts at 3–12 µg/mL significantly reduce chemically-induced DNA damage in human lymphocytes, and intestinal cell models show cytokine inhibition at 10–50 µg/mL concentrations. Rodent studies indicate that chestnut leaf and bark extracts can lower fasting blood glucose and improve lipid profiles at oral doses of 200–400 mg/kg body weight, though translating these doses to human equivalents requires caution. Overall, the evidence base is preliminary and no large randomized controlled trials in humans currently support therapeutic dosing recommendations for chestnut extract as a supplement.

Nutritional Profile

Chestnuts (Castanea sativa) are nutritionally distinct from most other nuts, being exceptionally low in fat (~2g per 100g fresh weight) and high in complex carbohydrates (~45g per 100g fresh weight, rising to ~76g dried). Protein content is modest at ~3-4g per 100g fresh weight, with a relatively favorable amino acid profile including lysine (~130mg/100g) and tryptophan. Fat composition is dominated by unsaturated fatty acids (oleic and linoleic acid comprising ~75% of total lipids). Dietary fiber content is significant at ~5-8g per 100g fresh weight, including both soluble and insoluble fractions supporting gut health. Micronutrients include notable potassium (~518mg/100g), phosphorus (~93mg/100g), magnesium (~32mg/100g), and iron (~1mg/100g). Vitamin C content is unusually high for a nut at ~43mg/100g fresh weight (approximately 48% RDI), though substantially reduced by cooking (~40-60% loss). B-vitamins are present including B6 (~0.5mg/100g), folate (~62µg/100g), and thiamine (~0.24mg/100g). Bioactive compounds include tannins (ellagitannins such as castalagin and vescalagin, ~2-10% dry weight in bark, lower in flesh), gallic acid, ellagic acid, and quercetin derivatives. Starch bioavailability is moderate due to resistant starch content (~2-5g/100g), contributing to a relatively low glycemic index (~54) compared to other starchy foods. Roasting increases sugar content through starch hydrolysis but reduces vitamin C and some polyphenols.

Preparation & Dosage

No clinically studied human dosages available. Preclinical studies used extract concentrations of 10-100 µg/mL for anti-inflammatory effects and 3-18 µg/mL for antimutagenic activity. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Green Tea Extract, Turmeric, Resveratrol, Grape Seed Extract

Safety & Interactions

Chestnut consumption as a food is generally recognized as safe for most adults, but concentrated bark or leaf extracts lack robust human safety trials and should be approached cautiously. Individuals with tree nut allergies should exercise caution, as cross-reactivity between Castanea sativa proteins and other nut allergens has been documented, with Cas s 8 identified as a lipid transfer protein allergen. The high tannin content in bark extracts may reduce oral iron absorption and could theoretically diminish the bioavailability of certain medications including iron supplements, tetracyclines, and alkaloid-based drugs if taken simultaneously. Pregnant and breastfeeding women should avoid concentrated chestnut extracts due to insufficient safety data, though whole chestnut consumed as food remains a standard dietary staple with no established concern.